Clarity Pharmaceuticals Ltd Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Clarity Pharmaceuticals Ltd Stock Forecast and Price Target
Clarity Pharmaceuticals Ltd's stock is projected to advance by -4.59% from the previous closing price if it reaches the average target of $3.12 by the year's end, as reputable analysts recently projected. This potential downside is calculated on a high-end estimate of $3.90 and a low-end estimate of $3.10.
-4.59% Downside
Clarity Pharmaceuticals Ltd Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Clarity Pharmaceuticals Ltd's Price has increased by 100.00%, going from $0.00 to $0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach $0.00 – an increase of 100.00%. The Clarity Pharmaceuticals Ltd forecast is for Fair Value to reach $0.00 or grow by 100.00%.
Clarity Pharmaceuticals Ltd Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Clarity Pharmaceuticals Ltd's Revenue has increased by 206.25%, going from $3.20M to $9.80M. According to 0 prominent analysts, Clarity Pharmaceuticals Ltd's Revenue will fall by 39.54% in the next year, reaching $5.93M. By 2030, professionals believe that Clarity Pharmaceuticals Ltd's Revenue will decrease by 34.00%, reaching $6.47M – a concerning trend for the company.
.jpg)
Clarity Pharmaceuticals Ltd EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Clarity Pharmaceuticals Ltd's EBITDA has grown, increasing from $-10.30M to $-26.26M – a growth of 154.95%. In the next year, 0 analysts estimate that Clarity Pharmaceuticals Ltd's EBITDA will decrease by 36.64%, reaching $-16.64M. According to professional forecasts, in 2030, Clarity Pharmaceuticals Ltd's EBITDA will decrease by 32.13%, reaching $-17.82M.
Clarity Pharmaceuticals Ltd EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Clarity Pharmaceuticals Ltd's EBIT has grown by 155.67%, from $-10.31M to $-26.36M. According to 0 analysts, Clarity Pharmaceuticals Ltd's EBIT will fall by 36.72% in the next year, reaching $-16.68M. Professionals believe that By 2030, Clarity Pharmaceuticals Ltd's EBIT will fall to $-17.88M – a 32.18% decrease from its current value.
Clarity Pharmaceuticals Ltd EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Clarity Pharmaceuticals Ltd's EPS has increased by 100.00%, going from $-0.09 to $0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach $0.00 – an increase of 100.00%. The Clarity Pharmaceuticals Ltd forecast is for EPS to reach $0.00 or grow by 100.00%.
Site Navigation
.jpg)